Rosen Robert 4
4 · Odonate Therapeutics, Inc. · Filed Jan 3, 2019
Insider Transaction Report
Form 4
Rosen Robert
Director
Transactions
- Award
Stock Option (Right to Buy)
2018-12-31+12,500→ 12,500 totalExercise: $14.08Exp: 2028-12-31→ Common Stock (12,500 underlying)
Footnotes (1)
- [F1]The stock options vest and become exercisable on December 31, 2019, subject to the Reporting Person's continued service to the Issuer through such date.